pain. Other preterm infants. 28 completed weeks or more but less than 37 completed weeks (196 completed days but less than 259 completed days) of gestation. Prematurity NOS
Conditions
Interventions
Intervention 1: Newborns of the mother milk group 9-16 hours before the study will be familiarized with their mother’s milk odor by an sterile swap perfumed with mother?s milk which its distance from
Prevention
Newborns of the mother milk group 9-16 hours before the study will be familiarized with their mother’s milk odor by an sterile swap perfumed with mother?s milk which its distance from the infant’s nos
Newborns of the vanilla group 9-16 hours before the study will be familiarized with vanilla Dissolved in glycerol odor by an sterile swap perfumed with vanilla Dissolved in glycerol which its distance
Newborns of the control group will not be familiarized with any odor before the study . Day of the study this group of infants during the 5 minutes before blood sampling, during sampling and 5 minutes
Sponsors
Deputy of Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 1 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:Having 28 to 34 weeks gestational age; Minimum age is 3 days, mother?s milk fed; having experienced the pain of previous sampling; drink milk or sweet liquids 30 minutes before the intervention; have not asphyxia, they have stability With specialist neonatal physiologic view; haven’t any congenital malformation Especially in the nose area; haven’t IVH or PVL; haven’t need to surgery; without mecanical ventilation or CPAP; Baby’s have willingness to participate in the study ? Exclusion criteria:Baby will be deleted from the study if the diagnosis neuromuscular complications and congenital abnormalities or create any item that would violate the entry criteria; Baby will be deleted from the study if it is not successful obtaining a blood sample with a disposable needle into the skin and need to again try from sampling; Baby will be deleted from the study if recorded films during the intervention are obscure.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 5 minute before blood sampling and during blood sampling and 5 minute after sampling. Method of measurement: with PIPP standard tool. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed